Torno Capital’s Guardant Health GH Stock Holding History

Torno Capital’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-19,300	Closed	-$398K	–	254
2024 Q1	$398K	Buy	+19,300	New	+$414K	0.03%	170

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Torno Capital's GH Position: Q2 2024 in Review

Torno Capital sold out of Guardant Health (GH) in Q2 2024, closing a stake of 25,000 shares — an estimated $516K sold.

Torno Capital first reported a position in GH in Q1 2024 and held it in 1 quarter. The position peaked at $516K in Q1 2024. 281 funds tracked by Wall St. Rank hold GH as of Q2 2024.

Torno Capital reported no remaining Guardant Health position as of Q2 2024 after selling out during the quarter.
Torno Capital sold 25,000 Guardant Health shares in Q2 2024, an estimated $516K.
Torno Capital first reported a position in Guardant Health in Q1 2024 and held it in 1 quarter.
Torno Capital's Guardant Health position peaked at $516K in Q1 2024.
281 funds tracked by Wall St. Rank held Guardant Health as of Q2 2024.

Based on Torno Capital's 13F filing for Q2 2024, filed 14 Aug 2024.